Infectious Enteritis Treatment Market

Infectious Enteritis Treatment Market : Global Industry Analysis 2015-2019 and Opportunity Assessment 2020-2030

Market Overview

Enteritis is inflammation of the small intestine. The major cause of enteritis is contaminated food and water with bacteria or viruses. Bacterial agents like Escherichia coli, toxigenic Clostridium difficileCampylobacter jejuni, and Vibrio cholerae are the major causes of infectious enteritis and disease is commonly known as bacteremia. These infectious agents then settle down in small intestine and cause swelling or inflammation. The major symptoms of infectious enteritis include fever, nausea, vomiting, diarrhoea etc. Among all the symptoms diarrhoea is highly prevalent. Disease conditions are most seen in under developed regions due to lack of awareness for personal hygiene and minimal healthcare expenditures. Initial infectious enteritis treatment may include fluid or electrolyte rehydration (ORS) and sometimes intravenous fluids. Ampicillin, Trimethoprim-sulfamethoxazole, Chloramphenicol, Tetracycline can be the first choice of antibacterial agents for infectious enteritis treatment. But with course of use these agents have developed resistance towards bacterial agents and hence probiotics can be the safest mode for infectious enteritis treatment. Lactobacillus reuteri, Lactobacillus rhamnosus, and the probiotic yeast Saccharomyces boulardii can help to treat diarrhoeal conditions in humans.

Infectious Enteritis Treatment Market: Drivers and Restraints

The rising population of diarrheal cases due to infectious enteritis especially in children is the major factor driving the growth of the infectious enteritis treatment market. According to WHO globally, there are nearly 1.7 billion cases of childhood diarrheal disease every year. These increasing prevalence of disease will help in driving the growth of infectious enteritis treatment market. The increasing application of drugs for the treatment of infectious enteritis such as Chloramphenicol and tetracycline are further expected to surge the growth of the infectious enteritis treatment market. Increasing FDA approvals of infectious enteritis treatment drugs are further expected to aid in the growth of the infectious enteritis treatment market. Intensive research and development activities to expand the therapeutic applications of infectious enteritis treatment drugs are further anticipated to support the growth of the infectious enteritis treatment market during the forecast years. The presence of a huge number of infectious enteritis treatment manufacturers is further boosting the growth of the infectious enteritis treatment market. However, there are several adverse effects associated with the treatment of infectious enteritis mainly resistance due to antibiotics, which in turn is hampering the growth of the infectious esophageal disorders treatment market. Lack of awareness among people in developing countries will also hamper the growth of   infectious enteritis treatment market.

Infectious Enteritis Treatment Market: Overview

Infectious Enteritis Treatment Market is expected to have robust growth over the forecast period. On the basis of route of administration type, the infectious enteritis treatment market is majorly dominated by the oral segment as this is the first line of treatment for infectious enteric disease. Among the drug type segment, antibiotic segment is expected to dominate the infectious enteritis treatment market due to maximum availability of products.  By end user, retail pharmacy is expected to dominate the infectious enteritis treatment market.

Infectious Enteritis Treatment Market: Regional Outlook

The North America is accounted for significant market share in terms of revenue and is expected to dominate the infectious enteritis treatment market over the forecast period. This is attributed to the increasing prevalence of infectious enteric disorders like diarrhoea in the region. Also, intensive research and development activities to expand the therapeutic application of infectious enteritis treatment drugs are further aiding in the growth of the infectious enteritis treatment market in the region. The Asia Pacific is expected to register prominent growth over the forecast period, owing to the increasing patients suffering from enteric infections and rising awareness of people towards the early treatment of infectious disorders. The higher disposable income of the people and increasing healthcare per capita is also contributing to the infectious infectious enteritis treatment market growth. The Middle East and Africa are projected to witness the least growth in the infectious enteritis treatment market, owing to the lack of awareness and least availability of infectious enteritis treatment in the region.

Infectious Enteritis Treatment Market: Key Players

The major in infectious enteritis treatment market are Abbott Laboratories, Baxter International, Pfizer, Bristol-Myers Squibb, Actelion Pharmaceuticals, Merck & Company, Lonza, BioGaia, ZBiotics company, Evolve Biosystems etc.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Indication
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Infectious Enteritis Treatment Market: Segmentation

The Infectious Enteritis Treatment Market can be segmented into Product type, Drug Type and End User

Based on by route of administration, the infectious enteritis treatment market is segmented into the following

  • Oral
  • Injectable

Based on drug type, the infectious enteritis treatment market is segmented into the following-

  • Antibiotics
  • Ampicillin
  • Chloramphenicol
  • Trimethoprim-sulfamethoxazole
  • Antivirals
  • Probiotics

Based on end user, the infectious enteritis treatment market is segmented into the following:

  • Hospital pharmacies
  • Retail pharmacy
  • Drug stores
  • Online Pharmacies

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Need specific information?

In the news

How Businesses Can Utilize Market Research to Create Reactive, Recession-proof Strategies for Survival

by - Sudip Saha, Managing Director and Co-Founder of Future Market Insights

Our Clients

View Our Reports from Healthcare

View Reports

Recommendations

Infectious Enteritis Treatment Market